---
title: Nuvisan vs Oncodesign Services
slug_a: nuvisan
slug_b: oncodesign-services
site: cro
review_signal_gate: closed
canonical_path: /compare/nuvisan/oncodesign-services
---

# Nuvisan vs Oncodesign Services

Side-by-side profile data from each company listing on this directory.

## Nuvisan

- Profile: [/companies/nuvisan](/companies/nuvisan)

Nuvisan — Full-service CRO and CDMO with specialized competency centers in drug discovery, formulation development, GMP manufacturing, and bioanalytical services across Germany and France.

Services: 32. Modalities: 2. Indications: 2. Locations: 8. Certifications: 0. The strongest documented coverage currently appears in services (32).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Protein Engineering
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- Bioanalysis
- Biomarker Assays
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Oncology Specialty Services
- Genomics & Sequencing Services
- Bioinformatics & Data Science
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Other)

### Indications

- Oncology
- Dermatology

### Phases

- Discovery
- Preclinical (General)
- Phase I
- Phase II

### Sourcing models

- Full-Service Outsourcing (FSO)

## Oncodesign Services

- Profile: [/companies/oncodesign-services](/companies/oncodesign-services)

Oncodesign Services — Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.

Services: 31. Modalities: 4. Indications: 9. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (31).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services

### Modalities

- Small Molecule
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Radiopharmaceutical

### Indications

- Oncology
- Immunology
- Metabolic
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Gastroenterology
- Nephrology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)